896 filings
Page 3 of 45
8-K
VXRT
Vaxart Inc
10 Jul 23
Vaxart Announces Positive Preliminary Topline Data from Dose-Ranging Phase 2 Study of its Bivalent Norovirus Vaccine Candidate
4:12pm
SC 13G/A
VXRT
Vaxart Inc
7 Jul 23
Vaxart / BlackRock ownership change
4:35pm
8-K
VXRT
Vaxart Inc
28 Jun 23
Submission of Matters to a Vote of Security Holders
4:22pm
DEFA14A
VXRT
Vaxart Inc
21 Jun 23
Additional proxy soliciting materials
5:18pm
4
VXRT
Vaxart Inc
14 Jun 23
Vaxart / Phillip E Lee ownership change
9:02pm
8-K
VXRT
Vaxart Inc
8 Jun 23
Vaxart, Inc. Announces Proposed Public Offering of Common Stock
4:27pm
424B5
VXRT
Vaxart Inc
8 Jun 23
Prospectus supplement for primary offering
4:17pm
424B5
VXRT
Vaxart Inc
6 Jun 23
Prospectus supplement for primary offering
5:21pm
8-K
VXRT
Vaxart Inc
6 Jun 23
No Vaccine Related Serious Adverse Events (SAEs) reported to date
8:07am
8-K
VXRT
Vaxart Inc
25 May 23
Other Events
4:31pm
4/A
VXRT
Vaxart Inc
11 May 23
Vaxart / Phillip E Lee ownership change
8:33pm
8-K
VXRT
Vaxart Inc
9 May 23
Vaxart Provides Business Update and Reports First Quarter 2023 Financial Results
4:57pm
424B5
VXRT
Vaxart Inc
9 May 23
Prospectus supplement for primary offering
2:41pm
EFFECT
VXRT
Vaxart Inc
8 May 23
Notice of effectiveness
12:15am
10-Q
2023 Q1
VXRT
Vaxart Inc
Quarterly report
4 May 23
4:05pm
CORRESP
VXRT
Vaxart Inc
3 May 23
Correspondence with SEC
12:00am
DEFA14A
VXRT
Vaxart Inc
28 Apr 23
Additional proxy soliciting materials
4:21pm
DEF 14A
VXRT
Vaxart Inc
Definitive proxy
28 Apr 23
4:20pm
8-K
VXRT
Vaxart Inc
31 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
UPLOAD
VXRT
Vaxart Inc
23 Mar 23
Letter from SEC
12:00am